Bactericidal activity in filtrated supernatant of Streptococcus Sanguinis against multidrug-resistant Pseudomonas Aeruginosa

Tohoku Journal of Experimental Medicine

Volumn 219, Issue 2, 2009, Pages 79-84

  Watanabe, Kiwao ^a   Senba, Masachika ^a   Ichinose, Akitoyo ^a   Yamamoto, Takeshi ^b   Ariyoshi, Koya ^a   Matsumoto, Keizo ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acinetobacter baumannii; Bactericidal effect; Multidrug resistant Pseudomonas aeruginosa; Pseudomonas aeruginosa; Streptococcus sanguinis

Indexed keywords

PROTEIN; PROTEINASE K;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ADULT; AGED; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONCENTRATION PROCESS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HUMAN; LUNG DISEASE; MALE; MORPHOLOGICAL TRAIT; MOUTH CAVITY; MULTIDRUG RESISTANCE; NONHUMAN; PROTEUS; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS SANGUINIS; SUPERNATANT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDOPEPTIDASE K; FEMALE; FILTRATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; STAINING AND LABELING; STERILIZATION; STREPTOCOCCUS; SUBCELLULAR FRACTIONS;

EID: 70449679040     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.219.79     Document Type: Article

References (22)

1. Basustaoglu, A.C., Gun, H., Saracli, M.A., Baysallar, M. & Haznedaroglu, T. (1995) Development of resistance to imipenem among nosocomial isolates of Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis., 14, 469-470.
2. Bonomo, R.A. & Szabo, D. (2006) Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis., 43 (Suppl 1), S49-56.
3. Campodonico, V.L., Gadjeva, M., Paradis-Bleau, C., Uluer, A. & Pier, G.B. (2008) Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol. Med., 14, 120-133.
4. Coykendall, A.L. (1989) Classification and identification of the viridans Streptococci. Clin. Microbiol. Rev., 2, 315-328.
5. D'Agata, E.M. (2004) Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: A 9-year surveillance study. Infect. Control Hosp. Epidemiol., 25, 842-846.
6. Dajani, A.S., Tom, M.C. & Law, D.J. (1976) Vridins, bacteriocins of alpha-hemolytic Streptococci: isolation, characterization, and partial purification. Antimicrob. Agents Chemother., 9, 81-88.
7. Equi, A., Balfour-Lynn, I.M., Bush, A. & Rosenthal, M. (2002) Long term azithromycin in children with cystic fibrosis: A randomised, placebo-controlled crossover trial. Lancet, 360, 978-984. (Pubitemid 35284109)
8. Falagas, M.E. & Kasiakou, S.K. (2005) Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis., 40, 1333-1341.
9. Ge, X., Kitten, T., Chen, Z., Lee, S.P., Munro, C.L. & Xu, P. (2008) Identification of Streptococcus sanguinis genes required for biofilm formation and examination of their role in endocarditis virulence. Infect. Immun., 76, 2551-2559.
10. Hachem, R.Y., Chemaly, R.F., Ahmar, C.A., Jiang, Y., Boktour, M.R., Rjaili, G.A., Bodey, G.P. & Raad, I.I. (2007) Colistin is effective in treatment of infectious caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob. Agents Chemother., 51, 1905-1911.
11. Keicho, N. & Kudoh, S. (2002) Diffuse panbrochiolitis: Role of macrolides in therapy. Am. J. Respir. Med., 1: 119-131.
12. Kudoh, S. & Keicho, N. (2003) Diffuse panbronchiolitis. Semin. Respir. Crit. Care Med., 24, 607-618.
13. Kreth, J., Zhang, Y. & Herzberg, M.C. (2008) Streptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans. J. Bacteriol., 190, 4632-4640. (Pubitemid 351898980)
14. Kukavica-Ibrulj, I. & Levesque, R.C. (2008) Animal models of chronic lung infection with Pseudomonas aeruginosa: Useful tools for cystic fibrosis studies. Lab. Anim., 42, 389-412.
15. Li, J., Nation, R.L., Turnidge, J.D., Milne, R.W., Coulthard, K., Royner, C.R. & Paterson, D.L. (2006) Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis., 6, 589-601.
16. Nouer, S.A., Nucci, M., de-Oliveira, M.P., Pellegrino, F.L. & Moreira, B.M. (2005) Risk factors for acquisition of multidrug-resistant Pseudomonas aeuginosa producing SPM metallo-beta-lactamase. Antimicrob. Agents Chemother., 49, 3663-3667.
17. Paterson, D.L. (2006) The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin. Infect. Dis., 43 (Suppl 2), S43-48.
18. Petrosillo, N., Ioannidou, E. & Falagas, M.E. (2008) Colistin monotherapy vs. combination therapy: Evidence from microbiological, animal and clinical studies. Clin. Microbiol. Infect., 14, 816-827.
19. Poole, K. (2004) Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect., 10, 12-26.
20. Rossolini, G.M. & Mantengoli, E. (2005) Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin. Microbiol. Infect., 11 (Suppl 4), S17-32.
21. Thomas, L.D., Dunkley, M.L., Moore, R., Reynolds, S., Bastin, D.A., Kyd, J.M. & Cripps, AW. (2000) Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung. Vaccine, 19, 348-357. (Pubitemid 30621529)
22. Winstanley, C. & Fothergill, J.L. (2009) The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiol. Lett., 290, 1-9.